1. Day CL, Jr., Sober AJ, Kopf AW, et al. A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg 1981 Apr;193(4):436–40.

2. Kopf AW, Rigel D, Bart RS, et al. Factors related to thickness of melanoma. Multifactorial analysis of variables correlated with thickness of superficial spreading malignant melanoma in man. J Dermatol Surg Oncol 1981 Aug;7(8):645–50.

3. Day CL, Jr., Sober AJ, Kopf AW, et al. A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg 1981 Aug;142(2):247–51.

4. Day CL. Jr., Mihm MC Jr., Sober AJ, et al. Prognostic factors for melanoma patients with lesions 0.76–1.69 mm in thickness. An appraisal of "thin" level IV lesion. Ann Surg 1982 Jan;195(1):30–4.

5. Woods JE, Taylor WF, et al. Is the BANS concept for malignant melanoma valid? Am J Surg 1985 Oct;150(4):452–55.

6. Rogers GS, Kopf AW, Rigel DS, et al. Influence of anatomic location on prognosis of malignant melanoma: attempt to verify the BANS model. J Am Acad Dermatol 1986 Aug;15(2):Pt

7. Blois MS, Sagebiel RW, Tuttle MS, et al. Judging prognosis in malignant melanoma of the skin: A problem of inference over small data sets. Ann Surg 1983;198:200–06.   

8. Cascinelli N, Vaglini M, et al. BANS. A cutaneous region with no prognostic significance in patients with melanoma. Cancer 1986 Feb;57(3):441–44.